Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review

Adverse drug events (ADEs) represent one of the most prevalent types of health-care-related harm, and there is substantial room for improvement in the way that they are currently predicted and detected. We conducted a scoping review to identify key use cases in which artificial intelligence (AI) cou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet. Digital health Jg. 4; H. 2; S. e137 - e148
Hauptverfasser: Syrowatka, Ania, Song, Wenyu, Amato, Mary G, Foer, Dinah, Edrees, Heba, Co, Zoe, Kuznetsova, Masha, Dulgarian, Sevan, Seger, Diane L, Simona, Aurélien, Bain, Paul A, Purcell Jackson, Gretchen, Rhee, Kyu, Bates, David W
Format: Journal Article
Sprache:Englisch
Veröffentlicht: England Elsevier Ltd 01.02.2022
Elsevier
Schlagworte:
ISSN:2589-7500, 2589-7500
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!